Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of antimalarial drugs. Its structure supports the inhibition of parasite growth by interfering with essential metabolic pathways in Plasmodium species. Also employed in the design of kinase inhibitors for potential anticancer therapies due to its ability to enhance binding affinity and metabolic stability. The trifluoromethoxy group improves lipophilicity and bioavailability, making it valuable in optimizing drug candidates. Additionally, it serves as a building block in agrochemicals for creating novel pesticides with improved environmental persistence and target specificity.